AdvisorShares迷幻药主动型ETF PSIL 深 沪
已收盘 04-02 16:00:00 美东时间
17.23
-0.159
-0.91%
华盛通- 最 高17.353
- 今 开16.86
- 成交量 6264股
- 最 低 16.86
- 昨 收 17.389
- 总市值 2041.71万
- 52周最高 19.9261
- 市盈率 静 --
- 换手率 0.53%
- 52周最低 8.8842
- 委 比 0.00%
- 总股本 118.50万
- 历史最高 104.3816
- 量 比 0.96
- 振 幅 2.84%
- 历史最低 5.9573
- 每 手 1
- 风险率 2.85%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多NRx Pharma Stock Jumps After FDA Signals Path To NDA For Ketamine Depression Drug
The FDA signals its willingness to review NRx Pharmaceuticals' NRX-100 NDA, boosting optimism around its depression treatment.
03-17 01:35
Pacifica Silver Expands Claudia Drilling and Bolsters Exploration Team
Pacifica Silver ( ($TSE:PSIL) ) has provided an update. Pacifica Silver has exp...
03-16 21:44
COMPASS Pathways Triumph In Hard To Treat Depression Ignites Investor Frenzy
Compass Pathways' stock surges after late-stage depression trial success.
02-17 22:12
BRIEF-Psyence BioMed Announces Approval For Use Of Psylabs’ Psilocybin Product In Phase IIb Clinical Trial
Dec 19 (Reuters) - Psyence Biomedical Ltd PBM.O: PSYENCE BIOMED ANNOUNCES APPROVAL FOR USE OF PSYLABS’ PSILOCYBIN PRODUCT IN PHASE IIB CLINICAL TRIAL PSYENCE BIOMEDICAL LTD: STUDY REMAINS ON TRACK TO ...
2025-12-19 20:06
Quantum Biopharma Reports Positive Phase 1 Safety For Multiple Sclerosis Drug
Quantum Biopharma's subsidiary, Huge Biopharma Australia, has cleared a regulatory milestone for its neuroprotective compound, Lucid-MS, in a Phase 1 trial.
2025-08-06 02:25
Ex-Gov't Foe Joins Trump, RFK Jr.'s HHS To Lead Psychedelics Policy: What It Means For Investors
Psychedelics litigator Matthew Zorn joins HHS under RFK Jr. to lead policy. What it means for CMPS, MNMD, CYBN, PSIL & more.
2025-05-25 04:11
BRIEF-Mercedes-Benz Announces Adam Chamberlain To Succeed Dimitris Psillakis As CEO Of Mercedes-Benz USA
April 15 (Reuters) - Mercedes-Benz Group AG MBGn.DE: MERCEDES-BENZ ANNOUNCES LEADERSHIP TRANSITION: ADAM CHAMBERLAIN TO SUCCEED DIMITRIS PSILLAKIS AS CEO OF MERCEDES-BENZ USA MERCEDES-BENZ USA: DIMITR...
2025-04-16 06:01
BRIEF-Benuvia Operations Awarded NIH Contract For GMP Synthesis Of Psilocybin And Other Bulk Drug Substances
March 25 (Reuters) - BENUVIA OPERATIONS- AWARDED NIH CONTRACT FOR GMP SYNTHESIS OF PSILOCYBIN AND OTHER BULK DRUG SUBSTANCES Source text: ID:nPn78PbBha ((Reuters.Briefs@thomsonreuters.com;))
2025-03-25 21:14
5 ETFs That Beat Market Turmoil With Gains Last Week
Last week had Wall Street facing volatility, tech earnings disappointments, mixed labor data, and rising inflation fears. Gold hit record highs.
2025-02-11 00:05
Psilocybin Drug By Psilera Could Treat Frontotemporal Dementia Without Psychoactive Effects
Psilera's trip-free psilocybin drug PSIL-006 clears key safety milestone, potentially offering a breakthrough treatment for frontotemporal dementia.
2024-09-10 02:09
